Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimisation of Immunosuppression in Elderly Renal Transplant Recipients
NCT05073822Phase 2Withdrawn
- Sponsor
- University College London
- Start
- Feb 2023
- Primary completion
- Feb 2027
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 2 trial of tacrolimus, mycophenolate mofetil in kidney transplant rejection, sponsored by University College London. Planned start Feb 2023; status: withdrawn.
02
Drugs
tacrolimusmycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT05073822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073822.